Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — 9M 2016 Earnings Presentation
18 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Nov 3, 2016
Slide 1: Conference call: Interim report January 1 to September 30, 2016
Conference call Interim report January 1 to September 30, 2016 Lübeck, November 3, 2016
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Business Highlights 9M
Business Highlights 9M Net Sales Order intake (currency adjusted): -1.1% -2.6% Q3 -1.7% yoy Currency 9M -0.3% yoy Currency adjusted 1,784 adjusted Gross profit margin: 604 Q3 44.0% (+2.2% yoy) 1,704 9M 43.9% (-0.6% yoy) 593 Functional expenses down year Q3‘15 Q3‘16 9M'15 9M'16 over year. Effic
Slide 4: Order development in 9M
Order development in 9M Order entry (€ million) Group Medical Safety Net Sales America 371 +5.4% +5.4% +5.2% -0.3% Africa, Asia, -1.6% -13.5% -4.9% 468 -5.0% Australia Europe 1,010 +0.1% +0.4% -0.5% -2.3% Group 1,849 -0.3% +0.9% -2.3% -2.6% Growth rates are net of currency effects 4
Slide 5: Group development 9M
Business development 9M Group Q3 2015 Q3 2016 Change 9M 2015 9M 2016 Change million € million € % million € million € % Order Intake 645.7 628.0 -2.7 1,895.1 1,849.1 -2.4 Net Sales 604.0 592.9 -1.8 1,783.6 1,704.3 -4.4 % growth (FX adjusted) 0.2% -1.1% 2.3% -2.6% Gross margin 41.8% 44.0% +2.2pp 44.5
Slide 6: Functional Expenses
Functional Expenses 9M 2015 9M 2016 Change Change net of currency effects million € million € % % R&D -174.9 -163.4 -6.6 -6.2 % of Net Sales -9.8% -9.6% Sales & Marketing -445.6 -404.4 -9.2 -7.9 % of Net Sales -25.0% -23.7% Administration -164.8 -150.1 -8.9 -8.0 % of Net Sales -9.2% -8.8% SG&A -610.
Slide 7: Key Figures
Key Figures 9M 2015 9M 2016 Change million € million € % Cashflow from operating activities -7.2 90.9 >100 Investments 156.7 71.1 -54.6 1 Cash and cash equivalents 128.7 173.9 35.1 1 Net financial debt 165.5 121.0 -26.9 1 2 0.91 0.68 Net financial debt /EBITDA 1 Capital employed 1,256.4 1,238.7 -1.4
Slide 8: Business development 9M
Business development 9M EBIT- Order entry Net sales Net sales EBIT margin ∆ in %* million € ∆ in %* million € % Europe 0.1 949.2 -2.3 25.7 2.7 America 5.4 335.9 -0.3 -8.7 -2.6 Africa, Asia, Australia -5.0 419.3 -4.9 11.0 2.6 Group -0.3 1704.3 -2.6 28.1 1.6 Medical 0.9 1093.9 -2.9 7.7 0.7 Safety -2.3
Slide 9: Outlook
Outlook 2015 2016e 2017e Net Sales + 2.9% Lower end of Slight increase (net of currency effects) 0.0% – 3.0% compared to prior year (net of currency effects) (net of currency effects) EBIT margin 2.6% 3.5% – 5.5%* improvement* Gross profit margin 44.9% Below prior year Cash flow from 59.8% > 60% ope
Slide 10: Questions & Answers
Questions & Answers Drager 10 Drager. Technik ftir das Leben®
Slide 11: Appendix
Drager Appendix
Slide 12: Segments development Q3
Business development Segments Europa Amerika Afrika, Asien, Australien Dräger Konzern Q3 2015 Q3 2016 Q3 2015 Q3 2016 Q3 2015 Q3 2016 Q3 2015 Q3 2016 million € million € million € million € million € million € million € million € Order entry 345.1 336.7 129.0 134.7 171.6 156.6 645.7 628.0 Net Sales
Slide 13: Segments development 9M
Business development Segments Europa Amerika Afrika, Asien, Australien Dräger Konzern 9M 2015 9M 2016 9M 2015 9M 2016 9M 2015 9M 2016 9M 2015 9M 2016 million € million € million € million € million € million € million € million € Order entry 1,024.2 1,009.9 368.2 371.2 502.7 468.0 1,895.1 1,849.1 Ne
Slide 14: Medical development
Business development Medical Q3 2015 Q3 2016 Change Change 9M 2015 9M 2016 Change Change million € million € % % (FX adj.) million € million € % % (FX adj.) Order entry 420.6 417.4 -0.8 0.5 1,235.0 1,218.1 -1.4 0.9 Europe 208.8 206.1 -1.3 0.1 620.9 614.5 -1.0 0.4 America 89.8 96.3 7.2 10.2 255.1 256
Slide 15: Safety development
Business development Safety Q3 2015 Q3 2016 Change Change 9M 2015 9M 2016 Change Change million € million € % % (FX adj.) million € million € % % (FX adj.) Order entry 225.2 210.6 -6.5 -5.9 660.0 631.0 -4.4 -2.3 Europe 136.3 130.6 -4.2 -3.1 403.2 395.4 -1.9 -0.5 America 39.2 38.4 -2.1 -1.5 113.2 115
Slide 16: Cash-flow statement
Cash-flow statement 9M 2015 9M 2016 Change million € million € % Group net profit -11.1 12.5 >100 Change in inventories -76.4 -59.1 22.7 Change in receivables 71.3 133.2 86.9 Change in payables -25.0 -31.0 -23.8 Depreciation and amortization 61.9 61.6 -0.5 Other operating cash flow items -27.9 -26.4
Slide 17: Financial calendar
Financial calendar March 8, 2017 - Accounts press conference, Lübeck - Analysts meeting May 4, 2017 - Report for the first three months 2017 Conference call, Lübeck May 10, 2017 - Annual shareholders' meeting, Lübeck July 27, 2017 - Report for the first six months 2017 Conference call, Lübeck Novemb
Slide 18: Contact
Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88
Drägerwerk AG & Co. KGaA — 9M 2016 Earnings Presentation on 6ix